LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

Clinical trial NCT04752722 · RECRUITING

Trial details

NCT number: NCT04752722
Sponsor: enGene, Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Superficial Bladder Cancer Non-muscle Invasive Bladder Cancer With Carcinoma in Situ Non-muscle Invasive Bladder Cancer

Start date: 2021-04-22
Primary completion: 2028-04-30
Enrollment: 350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.